BJU International

Article	Citations
Sexual function in adolescence after childhood hypospadias repair: a patient‐reported outcome study	91
Reply to ‘Comment on Bertini et al.: area deprivation and PSA screening disparities’ and ‘Comment on socioeconomic disparities in prostate cancer screening: the impact of the Area Deprivati	80
NeuroSAFE in radical prostatectomy increases the rate of nerve‐sparing surgery without affecting oncological outcome	64
Impact of the COVID‐19 pandemic on the burnout rates of graduating Canadian Urology residents	58
Response to Chen et al.	51
Risk factors and natural history of parastomal hernia after radical cystectomy and ileal conduit	51
Building a research profile during residency	51
The European Association of Urology talent incubator: bridging competencies for holistic urological care	46
April's reviewers of the month	45
Surveillance of non‐muscle ‐invasive bladder cancer with blue‐light cystoscopy: a meta‐analysis	45
Acupuncture: a promising adjuvant strategy for pain management among the patients with prostate cancer	44
April's reviewers of the month	42
	42
Efficacy of RestoreX after prostatectomy: open‐label phase of a randomised controlled trial	40
Prolonged ischaemia during partial nephrectomy: impact of warm vs cold	40
Aligning germline and somatic mutations in prostate cancer. Are genetics changing practice?	39
Nephrectomy for kidney tumour increases the risk of de novo arterial hypertension	37
Comparison of the effects of extrinsic compression on the drainage performance of three ureteric stents	36
Recent key papers in prostate cancer	35
Vitamin C as an adjunct to methenamine hippurate use after ALTAR: ego or evidence‐based?	33
The LANDMARK project: providing summaries of key papers that have shaped urological practice	32
Editorial Board	31
Real‐world performance of Uromonitor® in urothelial bladder cancer detection: a multicentric trial	31
Active surveillance versus enzalutamide for low‐risk prostate cancer – was it really a trial we needed?	31
	29

Author Index	29
Flexible ureterorenoscopy or extracorporeal shockwave lithotripsy in stone disease and bevacizumab for hereditary and sporadic papillary renal‐cell cancer	29
Comment on: ‘Residents surgical training using metrics for transurethral resection of bladder tumours’	28
MRI in combination with Technetium‐99m‐sestamibi single‐photon emission CT/CT: a novel diagnostic algorithm to maximise the characterisation of small renal masses	27
September's reviewers of the month	25
Feasibility and outcomes of interventions to reduce cystoscopy discomfort: a multi‐site pilot study	25
Association between total prostate‐specific antigen (tPSA), free/tPSA, and prostate cancer mortality	24
Age‐related PSA testing for prostate cancer: NICE recommendation 1.6.3	24
Eve's and Adam's rib for prostate cancer screening	24
MRI , Prostate cancer diagnosis, and Artificial Intelligence; What are the implications?	24
ChatGPT – Integrity: Artificial Intelligence Misuse in Medical Writing	24
Journal information	23
Is Artificial Intelligence Ready for “Primetime” in Urology?	23
Synchronous vs independent reading of prostate‐specific membrane antigen positron emission tomography ( PSMA‐PET) and magnetic resonance imaging (	23
Can exercise increase natural killer cell infiltration of the prostate?	21
Corrigendum	21
Should patients with non‐muscle‐invasive bladder cancer discontinue fibrin clot inhibitors during bacille Calmette–Guérin?	21
The impact of post‐nephroureterectomy surgically induced chronic kidney disease on survival outcomes	21
The effect of different assays on prostate‐specific antigen testing	21
Editorial Board	21
Incidence, risk factors, and temporal trends of penile cancer: a global population‐based study	21
September's reviewers of the month	20
Validation of a prediction model for post‐chemotherapy fibrosis in nonseminoma patients	20
Thulium fibre laser lithotripsy, the new standard?	20
Table of Contents	20
The rapid assessment for prostate imaging and diagnosis ( RAPID ) prostate cancer diagnostic pathway	20
Quality‐of‐life outcomes of the ROBOtic‐assisted versus Conventional Open Partial nephrectomy (ROBOCOP) II trial	20
Caval thrombectomy a urological leap into the unknown – a call for action	19
Why prompting matters: achieving clinically accurate and consistent responses with Chat GPT	19
	19
	19
Analgesic efficacy of rectus sheath catheter is non‐inferior to thoracic epidural catheter	19
August's reviewers of the month	19
‘Igloo’ technique for robot‐assisted radical prostatectomy – maximum nerve sparing for early recovery of continence and sexual function	19
Editorial Board	18
How prostate‐specific membrane antigen positron emission tomography is refining risk calculators in the primary prostate diagnostic pathway	18
	18
Issue Information	18
Sustainability in urology – are we doing enough?	18
Sepsis prevalence and associated hospital admission and mortality after ureteroscopy in employed adults	17
Progress in the management of stone disease	17
A meta‐analysis of Retzius‐sparing and hood‐technique robot‐assisted radical prostatectomy	17
VI‐RADS followed by Photodynamic Transurethral Resection of Non‐Muscle‐Invasive Bladder Cancer vs White‐Light Conventional and Second‐resection: the ‘CUT‐ less	17
Comparison of serum and plasma microRNA expression levels in patients with germ cell tumours	17
Preferences between three options for androgen deprivation therapy: a focus group study	17
Can only AI save us from the burden of administration?	17
Reply to ‘A mitochondrion‐centric approach to guide treatment de‐escalation in advanced prostate cancer’ by Su et al.	16
The diagnostic value of MRI for persistent prostate cancer following irreversible electroporation focal therapy	16
Opportunistic prostate‐specific antigen testing in Norwegian men: a public health challenge	16
Is Gleason 6 cancer? The answer is more than just a ‘name’	16

Ureterorenoscopy during normothermic machine perfusion: effect of varying renal pelvis pressure	16
Blue vs white light for transurethral resection of non‐muscle‐invasive bladder cancer: an abridged Cochrane Review	16
A novel flexible vacuum‐assisted ureteric access sheath in retrograde intrarenal surgery	16
Key ingredients for running a randomised controlled trial in a surgical day unit	15
Mesorectal nodal metastasis with seminal vesicle invasion in biochemically recurrent prostate cancer	15
In vivo ureteroscopic intrarenal pressures and clinical outcomes: a multi‐institutional analysis of 120 consecutive patients	15
Functional outcomes of robot‐assisted partial nephrectomy in patients with a solitary kidney	15
International Alliance of Urolithiasis guideline on retrograde intrarenal surgery	15
Editorial Board	15
	15
‘ Case of the Month’ from the First Hospital of Sanming, Fujian Medical University, China: management of a renal haematoma with pyelonephritis and ne	15
An MRI/PET PSMA‐based phase I–II study of salvage high‐dose‐rate brachytherapy after surgery and radiotherapy	15
Definitive local therapy for T4 prostate cancer associated with improved local control and survival	14
Editorial Board	14
Response to ‘Endpoint and control group in prostate cancer screening research: public health basics’	14
Development of an optically transparent kidney model for laser lithotripsy research	14
Vascular closure devices in living‐donor nephrectomy: a much‐needed systematic review and meta‐analysis focusing on safety	14
Journal information	14
Pre‐versus postnatal presentation of posterior urethral valves: a multi‐institutional experience	14
Cystectomy and lymphadenectomy – we now node how far to go!	14
Non‐infectious adverse events of transperineal prostate biopsies performed under local anaesthesia	14
Repeat MRI during active surveillance: natural history of prostatic lesions and upgrading rates	14
Potential safety concerns in use of the artificial intelligence chatbot ‘ChatGPT’ for perioperative patient communication	14
Improving detection of carcinoma in situ in bladder cancer: urinary cytology vs the Xpert® BC Monitor	13
Urologist underutilisation of androgen receptor pathway inhibitors for metastatic hormone‐sensitive prostate cancer	13
Response to Zhu et al.	13
Inhibition of phosphodiesterases 1 and 4 prevents myofibroblast transformation in Peyronie's disease	13
Case of the Month from UCSD, San Diego, USA: Treatment of giant dystrophic prostatic calcification using MOSES holmium laser	13
High prostate‐specific membrane antigen ( PSMA) positron emission tomography (PET) maximum standardized uptake value in men	13
Comment on ‘Clinical features of medication‐related osteonecrosis of the jaw in prostate cancer management’	13
	13
Issue Information	13
Hydraulic and malleable female‐to‐male penile implants after phalloplasty in transgender individuals: a retrospective cohort analysis	13
Prevalence of germline pathogenic variants in 779 patients with metastatic prostate cancer	13
Scribe smarter, not harder: how artificial intelligence scribes stack up against human clinicians	12
Editorial Board	12
Re‐defining the interpretation of 24‐h urine studies for stone formers	12
Developing an artificial intelligence model for phase recognition in robot‐assisted radical prostatectomy	12
November's reviewers of the month	12
Evaluating the predictors of poor corporal integrity in penile implant recipients	12
Clinical presentation of bacille Calmette–Guérin ( BCG ) infections after	12
Bladder irrigation with tap water to reduce antibiotic use for urinary tract infections in catheter users	12
	12
Journal information	12
The importance of the urologist in male oncology fertility preservation	12
	12
Issue Information	12
Single‐port robot‐assisted nephroureterectomy via a supine anterior approach: step‐by‐step technique	12
Global Urology, Urolink, and the BJUI	11
Use of a microdebrider for epithelial excision during vaginectomy/colpocleisis in patients undergoing metoidioplasty	11
Comment on ‘Can ChatGPT pass the urology fellowship examination? Artificial intelligence capability in surgical training assessment’	11
Recovery and immune function after low pressure pneumoperitoneum during robot‐assisted radical prostatectomy: a randomised controlled trial	11
The value of maintenance therapy in intermediate‐risk non‐muscle‐invasive bladder cancer	11
First‐line programmed death receptor‐1 ( PD ‐1) inhibitor and epidermal growth factor receptor (EGFR) blockade, combined with platinum‐based chemothe	11
Perspectives on technology: Single‐use catheters – evidence and environmental impact	11
Learning curve for fusion magnetic resonance imaging targeted prostate biopsy and three‐dimensional transrectal ultrasonography segmentation	11
Reduced‐dose bacillus Calmette‐Guérin (BCG) in an era of BCG shortage: real‐world experience from a tertiary cancer centre	11
Greenlight laser prostatectomy: which goggles are best for visualising haematuria accurately?	11
Contemporary outcomes in non‐muscle‐invasive bladder cancer: a large European multicentre study	11
Issue Information	11
Cisplatin‐ineligible patients with muscle‐invasive bladder cancer demonstrate poor long‐term survival following immediate radical cystectomy	11
Initial surveillance in men with marker negative clinical stage IIA non‐seminomatous germ cell tumours	11
Google infodemiology and temporal trends in benign prostatic hyperplasia surgery in Australia	11
Oncological outcomes after attempted nerve‐sparing radical prostatectomy (NSRP) in patients with high‐risk prostate cancer are comparable to standard non‐NSRP: a longitudinal long‐term propensity‐matc	11
The challenges of conducting a surgical trial—reflections on the en bloc resection of urothelium carcinoma of the bladder (EBRUC) II trial	11
There is more to disposable endoscopes than whether they work…	11
Clinicopathological predictors of finding additional inguinal lymph node metastases in penile cancer patients after positive dynamic sentinel node biopsy: a European multicentre evaluation	11
Female non‐obstetric urogenital fistula repair: long‐term patient‐reported outcomes and a scoping literature review	11
Table of Contents	10
Outcomes after laser enucleation of the prostate with and without significant storage symptoms	10
Table of Contents	10
Positive surgical margin and oncological outcomes after robot‐assisted radical prostatectomy in different Cancer of the Prostate Risk Assessment risk groups	10
Emergency department visits for radiation cystitis among patients with a prostate cancer history	10
Iatrogenic ureteric injury during abdominal or pelvic surgery: a meta‐analysis	10
Accurate diagnosis of prostate cancer by combining Proclarix with magnetic resonance imaging	10
Recommendation on the use of protective eyewear in endourological laser procedures	10
Prognostic value of programmed death ligand‐1 and programmed death‐1 expression in patients with upper tract urothelial carcinoma	10
Acute Urinary Retention and Cancer; Is It All About the Prostate?	10
Neural monitoring of central responses to lower urinary tract function	10
Impact of intraprostatic PSMA maximum standardised uptake value following prostatectomy: a systematic review and meta‐analysis	10

Irreversible electroporation of localised prostate cancer downregulates immune suppression and induces systemic anti‐tumour T‐cell activation – IRE ‐	10
Total pelvic exenteration surgery for loco‐regionally advanced prostate cancer, is it justifiable?	10
A luminal non‐coding RNA‐based genomic classifier confirms favourable outcomes in patients with clinically organ‐confined bladder cancer treated with radical cystectomy	10
Sarcopenia may increase cisplatin toxicity in bladder cancer patients with borderline renal function	10
Surgical cystectomy training using human cadavers embalmed using Thiel's method: a pilot study	10
Prognostic importance of concomitant non‐regional lymph node and bone metastases in men with newly diagnosed metastatic prostate cancer	10
Stone volume instead of maximum stone diameter: results from an international survey	10
A randomized controlled trial investigating rectus sheath catheters following radical cystectomy	9
A systematic review on artificial intelligence evaluating PSMA PET scan for intraprostatic cancer	9
Immunotherapy‐based neoadjuvant treatment and complication rates after radical cystectomy	9
Retzius‐sparing robot‐assisted radical prostatectomy in renal transplant recipients	9
Increasing trend of utilising active surveillance for Gleason Score 7 (3 + 4) prostate cancer	9
August's reviewers of the month	9
Alternative instillation techniques of sequential intravesical gemcitabine and docetaxel for non‐muscle‐invasive bladder cancer	9
Systematic review of PSA reference intervals in the gender diverse population with prostates	9
June's reviewers of the month	9
Editorial Board	9
January’s reviewers of the month	9
F‐SHARP: a Phase I/II trial of focal salvage high‐dose‐rate brachytherapy for Radiorecurrent prostate cancer	9
A novel two‐stage approach to the treatment of renal cell carcinoma with intra‐cardiac tumour extension and Budd–Chiari syndrome	9
Added value of randomised biopsy to multiparametric magnetic resonance imaging‐targeted biopsy of the prostate in a contemporary cohort	9
Robot‐assisted single‐port transvesical enucleation of the prostate: step‐by‐step technique and early single‐centre experience	9
Post‐prostatectomy anastomotic stenosis: systematic review and meta‐analysis of endoscopic treatment	8
Real‐world outcomes for high‐risk non‐muscle‐invasive bladder cancer: screened patients for the BRAVO trial	8
Re: ‘The perioperative outcomes of papillary versus non‐papillary access in percutaneous nephrolithotomy’	8
A randomised trial comparing transurethral to percutaneous cystolithotripsy in boys	8
Nomograms including the UBC ® Rapid test to detect primary bladder cancer based on a multicentre dataset	8
A mitochondrion‐centric approach to guide treatment de‐escalation in advanced prostate cancer	8
Economic analysis of minimally invasive surgical treatments for BPH in the Australian public healthcare system	8
The first step in shared decision‐making for prostate cancer screening	8
Big trials in prostate cancer | predicting drug response in bladder cancer | immune checkpoint inhibitors for urothelial carcinoma | hydrochlorothiazide in the prevention of kidney stone recurrence	8
Clinicopathological analysis and outcomes of inflammatory myofibroblastic tumours of the urinary bladder	8
Response to Daungsupawong and Wiwanitkit: RE: The psychosocial impact of prostate cancer screening for BRCA1 and BRCA2	8
A TREXIT Catalyst: an updated review of NHS England prostate biopsy data during	8
A comment on: ‘Prevalence of urolithiasis in China: a systematic review and meta‐analysis’	8
Socioeconomic disparities in prostate cancer screening: the impact of the Area Deprivation Index on PSA screening frequency	8
Long‐term multicentre analysis of robot‐assisted radical cystectomy for non‐muscle‐invasive bladder cancer	8
	8
Editorial Board	8
Issue Information	8
Editorial Board	8
Metastatic risk in clear cell renal cell carcinoma: a tool incorporating sex, size, and grade	8
Stapled vs totally handsewn robotic intracorporeal neobladder: perioperative and functional outcomes	8
Confocal laser microscopy for assessment of surgical margins during radical prostatectomy	7
Is analgesic efficacy of rectus sheath catheter actually non‐inferior to thoracic epidural catheter?	7
Salvage stereotactic ablative body radiotherapy after thermal ablation of primary kidney cancer	7
Use of bulbospongiosus muscle for repair of traumatic posterior urethral stenosis combined with urethrorectal fistulas	7
Intravenously engrafted human multilineage‐differentiating stress‐enduring (Muse) cells rescue erectile function after rat cavernous nerve injury	7
Technetium‐99 m‐sestamibi single‐photon emission computerised tomography (CT)/CT in the prediction of malignant versus benign small renal masses	7
Comment on ‘Renal, bladder and prostate cancer surgery outcomes with respect to team familiarity’	7
Novel bioabsorbable, low‐dose rate brachytherapy device (CivaSheet ® ) with radical prostatectomy and adjuvant externa	7
Do not treat Bill Gates for prostate cancer! Algorithmic bias and causality in medical prediction	7
Response to the letter by Kleebayoon et al. Re: Sui et al. ‘Re‐defining the interpretation of 24‐h urine studies for stone formers’	7
Villis Marshall Presentation	7
Keith Kirkland Presentation	7
Prognostic impact of histological discordance between transurethral resection and radical cystectomy	7
B ladder‐centric benign prostatic hyperplasia management post‐laser enucleation of the prostate	7
Case of the Month from San Raffaele Hospital, Milan, Italy: paraneoplastic presentation of small renal masses	7
Unravelling the evolution of medical scientific publishing to hold the promise of science for better patient care	7
Accuracy of MRI in detecting seminal vesicle invasion in prostate cancer: a systematic review and meta‐analysis	7
Comment on ‘Stone dust in endourology: a systematic review of its definition, management, and clinical impact’	7
Is solo indocyanine green‐guided lymphadenectomy a feasible alternative to standard pelvic lymph node dissection?	7
Perspectives on technology: All STEPS count – an integrated framework for net zero urological care	7
Journal information	7
Molecular margin status after radical prostatectomy using glutathione S‐transferase P1 ( GSTP1 ) promoter hypermethylation	7
Risks and benefits of partial nephrectomy performed with limited or with zero ischaemia time	7
Low‐ versus standard‐ pneumoperitoneum in patients undergoing robot‐assisted radical prostatectomy: a randomised, triple‐blinded study	7
Clinical features of medication‐related osteonecrosis of the jaw in prostate cancer management	7
Abstract	7
	7
The growing valuable role of urology clinical nurse specialists in the United Kingdom	7
Adverse in‐hospital outcomes in patients with paraplegia who undergo radical prostatectomy	7
	7
Efficacy of indocyanine green fluorescence‐guided inguinal lymph node dissection for penile cancer: a randomised trial	7
Uretero‐enteric stricture outcomes: secondary analysis of a randomised controlled trial comparing open versus robot‐assisted radical cystectomy	7
Concurrent Session Presentations	7
Three‐dimensional virtual reconstruction guides robot‐assisted partial nephrectomy in a horseshoe kidney	6
Accuracy of cognitive vs software‐guided MRI ‐targeted biopsy in predicting final grading at prostatectomy	6
Temporal trends and clinical determinants of urinary diversion after radical cystectomy	6
Response to Brönimann et al. 'The Challenges of Conducting a Surgical Trial – Reflections on the EBRUC II Trial'	6
Issue Information	6
Addition of neoadjuvant chemotherapy to a ‘quadrifecta’ composite in radical cystectomy	6
The role of PSMA PET / CT in staging patients with intermediate‐risk prostate cancer	6
Response to Takahashi	6
EndoSheath use in flexible cystoscopy: a prospective evaluation of >1000 cases	6
Depictions of penises in historical paintings reflect changing perceptions of the ideal penis size	6
Issue Information	6
Versius robotic surgical system: case series of 18 robot‐assisted radical prostatectomies	6
Conservative management in high‐grade renal trauma: a systematic review and meta‐analysis	6
Comment on ‘Peri‐operative outcomes of open, laparoscopic and robotic simple prostatectomy’	6
External validation of the Uromonitor®‐version 2 urine test as a biomarker for optimisation of non‐muscle‐invasive bladder cancer management	6
Reply to ‘Letter Re: Ejaculatory function following transperineal laser ablation vs TURP for benign prostatic obstruction’	6
The role of testicular ultrasonography as a screening tool for testicular dysfunction in hypospadias	6
Incidence and risk factors for postoperative vaginal events following radical cystectomy for bladder cancer: a nationwide population‐based study	6
Impact of performance status on efficacy of systemic therapy for prostate cancer: a meta‐analysis	6